SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-004051
Filing Date
2019-12-23
Accepted
2019-12-23 16:37:09
Documents
61
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-10312019.htm 10-Q 473161
2 SUBSCRIPTION AGREEMENT pharmacyte_ex0304.htm EX-3.4 47026
3 VOTING RIGHTS AGREEMENT pharmacyte_ex0305.htm EX-3.5 55733
4 PRINCIPAL EXECUTIVE OFFICER CERTIFICATION pharmacyte_ex3101.htm EX-31.1 8745
5 PRINCIPAL FINANCIAL OFFICER CERTIFICATION pharmacyte_ex3102.htm EX-31.2 8732
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3201.htm EX-32.1 4289
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3202.htm EX-32.2 4423
  Complete submission text file 0001683168-19-004051.txt   3292172

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE pmcb-20191031.xml EX-101.INS 593588
9 XBRL SCHEMA FILE pmcb-20191031.xsd EX-101.SCH 36760
10 XBRL CALCULATION FILE pmcb-20191031_cal.xml EX-101.CAL 40166
11 XBRL DEFINITION FILE pmcb-20191031_def.xml EX-101.DEF 174229
12 XBRL LABEL FILE pmcb-20191031_lab.xml EX-101.LAB 261942
13 XBRL PRESENTATION FILE pmcb-20191031_pre.xml EX-101.PRE 234341
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 191306576
SIC: 2836 Biological Products, (No Diagnostic Substances)